RemAb Therapeutics

Description: RemAb Therapeutics develops glycoconjugates to treat infections by removing interfering antibodies, aiming to lead in Gram-negative infection solutions.

Country: Spain

Based in: Barcelona

Founded: 2018

Funding Stage: Pre-Seed

Tags: ['Biotechnology', 'Health Care', 'Medical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.